The associates of anxiety among lung cancer patients: Dehydroepiandrosterone (DHEA) as a potential biomarker

BMC Cancer

Table 4 Subgroup analysis and multivariate linear regression model for statistically significant anxiety-related variables in lung cancer patients

Significant variables of different groups	Multivariate analysis
Significant variables of different groups	Beta	P value	adjusted R²	VIF
LC patients			0.412	1.204
PTSSs	0.332	< 0.001
CRF	0.247	0.02
Subgroup analysis
Chemotherapy
Yes
DHEA	0.346	0.001	0.451	1.255
PTSSs	0.407	0.001
CRF	0.326	0.011
No
EQ-VAS	-0.605	0.001
Surgery
Yes
DHEA	0.276	0.023	0.469	1.282
No
DHEA	0.322	0.022
CRF	0.374	0.017
Cancer stage
Early stage (0-II)		No significance
Advanced stage (III-IV)
DHEA	0.319	0.004	0.426	1.221
PTSSs	0.396	0.001
CRF	0.289	0.027

ISSN: 1471-2407